Dr. Benjamin H. Krasne, M.D.
Board-certified physicianBoard-certified in anesthesiology, he reads medications and metabolism with a pharmacologist's eye, which shapes how he doses weight loss and longevity care.
Approved weight-loss options, available now
Retatrutide: FDA status and approved alternatives
Retatrutide is an experimental weight-loss injection still in clinical trials. It is not FDA-approved, and we do not prescribe or sell it. Here is what is known and which approved medicines are available now.
- Retatrutide is not FDA-approved
- Free 5–10 minute consultation
- Approved injections and pills reviewed
Free to book. You pay only if you go ahead with treatment.
Freeconsultation
Licensed U.S. clinician review
Access: Clinical trials only
Freeconsultation
5–10 minphone or video
No insuranceneeded
LicensedU.S. clinicians
Retatrutide alternatives through My IV Doctors
Straight answers on status
Retatrutide is still in clinical trials. We don't prescribe or sell it, and we'll explain plainly what that means for you.
Approved options today
A licensed clinician checks whether FDA-approved medicines such as Wegovy, Zepbound or Foundayo fit your health, so you don't have to wait on an experimental drug.
Injection or pill
Compare weekly injections with daily pills that are available now, and choose the routine that suits you best with your clinician's guidance.
Safer than research peptides
Unapproved retatrutide sold online may be of unknown quality and sterility. A prescription for an approved option comes with a label, monitoring and follow-up visits.
How to get an approved alternative to retatrutide
- 1
Pick a time for your free visit
Choose a phone or video slot. The visit is about approved options, not retatrutide.
- 2
Talk with a clinician
A licensed U.S. clinician goes over your weight, health conditions, medicines and any GLP-1 you have tried.
- 3
Compare approved medications
Your clinician explains which FDA-approved options suit you and how they compare, including cost.
- 4
Start treatment if appropriate
If an approved medicine is right for you, your clinician prescribes it and arranges follow-up. If not, they explain why and what else may help.
Who can get retatrutide?
Joining a clinical trial
Clinical trials are the main legitimate way to receive retatrutide right now; the manufacturer also runs a small expanded access program for some patients who can't enroll in a trial. Search ClinicalTrials.gov for studies that are enrolling, and check each study's eligibility rules.
Want treatment now
Approved options such as tirzepatide (Zepbound) and semaglutide (Wegovy) act on some of the same pathways and can be prescribed after a clinician's assessment.
Prefer a pill
The Wegovy pill and Foundayo are daily GLP-1 pills approved for weight management.
Seen it for sale online
Products sold as research peptides or not for human use are unapproved and unregulated. The FDA has warned companies selling retatrutide this way. Do not inject them.
Have type 2 diabetes
Mounjaro, Ozempic and other approved medicines can be considered for blood sugar control.
Retatrutide vs. approved weight-loss medications
| Medication | Hormone targets | FDA status | Can we prescribe it? |
|---|---|---|---|
| Retatrutide | GLP-1, GIP and glucagon | Investigational, not approved | No |
| Tirzepatide (Zepbound) | GLP-1 and GIP | Approved for weight management and sleep apnea | Yes, when appropriate |
| Semaglutide (Wegovy injection or pill) | GLP-1 | Approved to manage weight | Yes, when appropriate |
| Orforglipron (Foundayo) or liraglutide | GLP-1 | Approved daily pill or injection | Yes, when appropriate |
Retatrutide, explained
Retatrutide is an investigational medicine being developed by Eli Lilly. It is a once-weekly injection designed to act on three hormone receptors at once: GLP-1, GIP and glucagon. The GLP-1 and GIP actions are the same pair targeted by tirzepatide, which reduce appetite and improve blood sugar. The added glucagon action is being studied for its possible effect on how much energy the body uses.
As of October 2026, retatrutide has not been approved by the FDA for any use. It is being tested in large phase 3 trials in people with obesity, type 2 diabetes, knee osteoarthritis and sleep apnea. The manufacturer has said publicly that it plans to apply for approval but had not submitted an application when this page was reviewed, and approval is never certain until the agency reviews the full data.
Because it is not approved, retatrutide is available only through clinical trials or a small manufacturer-run expanded access program for certain patients who can't join a trial. No legitimate U.S. pharmacy can dispense it on a regular prescription. My IV Doctors does not prescribe, sell or source retatrutide. What we can do is assess you for FDA-approved medicines that are available today.
Retatrutide vs. tirzepatide and semaglutide
Each of these targets the gut-hormone system in a different way. Only the first three groups are FDA-approved and available by prescription.
- Semaglutide (Wegovy injection, Wegovy pill): GLP-1 only; approved for weight management
- Tirzepatide (Zepbound): GLP-1 and GIP; approved for weight management and sleep apnea
- Liraglutide and orforglipron: daily GLP-1 options, by injection or pill
- Retatrutide: GLP-1, GIP and glucagon; investigational and not approved
Retatrutide research peptides: the risks
Websites sometimes sell retatrutide labeled for research or not for human consumption, often with dosing tips. The FDA has said these products are unapproved, of unknown quality and may be harmful. You cannot know what is in the vial, how much of it there is or whether it is sterile.
Trial participants are monitored closely by research teams with emergency plans in place. Injecting an unregulated product at home gives you none of that protection. If you have already used one and feel unwell, seek medical care and tell the clinician what you took.
Retatrutide FDA approval: what comes next
Approval would require the FDA to review the completed trials and decide that the benefits outweigh the risks for a specific group of patients. If retatrutide is approved in the future, this page will be updated with what that approval covers. Until then, treat claims of prescriptions or sales with caution.
Retatrutide side effects and safety
Safety information on retatrutide comes only from clinical trials and is still being collected. It has no FDA-approved label, warnings or dosing.
- Trial participants most often reported nausea, diarrhea, vomiting, constipation and reduced appetite, similar to other incretin medicines
- Long-term safety has not been established
- Unapproved products sold online may contain the wrong substance, the wrong amount or contaminants
- Never combine an unapproved product with a prescribed GLP-1 or tirzepatide
- Approved alternatives have FDA labels with known warnings, such as the thyroid C-cell tumor boxed warning, which your clinician reviews with you
Physicians who oversee your care
Independently licensed U.S. physicians supervise every treatment we offer.
Dr. Johnathan Chance Miller, M.D.
PhysicianTrained at Columbia and Washington University, he pairs prescriptions with practical habits around food, training and sleep.
Dr. Vanessa Niles, R.N., M.D., F.A.C.O.G.
OB-GYN, board certifiedAn OB-GYN for more than 40 years and a Fellow of ACOG, she leads women's health care, from perimenopause to PCOS.
Retatrutide: your questions
Still deciding? The first consultation is free and takes about 5–10 minutes.
Book a free consultationDoes retatrutide have FDA approval yet?
No. As of October 2026, retatrutide is still investigational and has not been approved by the FDA for any condition.
Can I be prescribed retatrutide online?
No. Because it is not approved, it can't be prescribed through a regular pharmacy. Access is limited to clinical trials and a small manufacturer-run expanded access program. We do not prescribe it, but we can assess you for approved alternatives.
When will retatrutide be available?
No one can say for sure. The manufacturer has said it plans to seek approval, but the FDA must review the data first, and that process takes time and is not certain to end in approval.
What separates retatrutide from tirzepatide?
Tirzepatide acts on GLP-1 and GIP receptors. Retatrutide adds a third target, the glucagon receptor. Tirzepatide is approved and available; retatrutide is not.
Is research peptide retatrutide safe?
No. These products are unapproved and unregulated, and the FDA has warned companies selling them. Their contents, strength and sterility cannot be trusted.
How can I join a retatrutide trial?
Search for retatrutide on ClinicalTrials.gov. Each listing explains who can take part and how to contact the study site.
What are the alternatives to retatrutide?
FDA-approved options include tirzepatide (Zepbound), semaglutide (Wegovy injection or pill), liraglutide and Foundayo. A clinician can help you choose.
Can I buy retatrutide online?
No. We do not prescribe, sell or source retatrutide in any form.
Can a compounding pharmacy make retatrutide?
Retatrutide is not an approved drug, and the FDA has warned about unapproved retatrutide products. Be wary of any pharmacy, clinic or website that offers it.
How much weight did people lose in retatrutide trials?
Trial results have been reported by the manufacturer, but they have not yet been reviewed by the FDA for an approval decision. Your clinician can explain the published evidence for approved medicines that you can actually start.
Is retatrutide the strongest weight-loss drug?
It is too early to say. Comparisons need completed trials and an FDA review. For now, tirzepatide and semaglutide are among the approved options with the strongest evidence.
What should I do if I used retatrutide from an online seller?
Stop using it and talk with a clinician, especially if you have stomach pain, vomiting, a fast heartbeat or signs of an allergic reaction. Bring the product details if you can.
How much does a weight loss consultation cost?
Booking a first consultation is free, and you do not need insurance. If you start an approved medicine, your clinician confirms its price before prescribing.
Explore retatrutide alternatives with a free consult
Retatrutide isn't available by prescription. Book a free 5–10 minute phone or video visit, and a licensed clinician will tell you whether an approved medicine fits you.
Related treatments
References
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss
- ClinicalTrials.gov: Retatrutide in type 2 diabetes with obesity or overweight (NCT05929079)
- MedlinePlus: Tirzepatide injection
- MedlinePlus: Semaglutide injection
Medically reviewed October 2026. This page is general information and not a substitute for advice from your own clinician. Read our editorial policy.
Freeconsultation
Book a free consultation